| License: Creative Commons Attribution 4.0 (6MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-401283
- DOI to cite this document:
- 10.5283/epub.40128
Abstract
Objective: To evaluate safety, tolerability and feasibility of long-term treatment with Granulocyte-colony stimulating factor (G-CSF), a well-known hematopoietic stem cell factor, guided by assessment of mobilized bone marrow derived stem cells and cytokines in the serum of patients with amyotrophic lateral sclerosis (ALS) treated on a named patient basis. Methods: 36 ALS patients were treated ...
Owner only: item control page